{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:13:59Z","timestamp":1789146839316,"version":"build-2803163510"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca PLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.lungcan.2026.109558","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:17:15Z","timestamp":1785770235000},"page":"109558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Biology, detection, and management of incidental pulmonary nodules: the emerging role of targeted treatments. A review of the current literature and future perspectives"],"prefix":"10.1016","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3053-3997","authenticated-orcid":false,"given":"Ross A.","family":"Soo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5033-0006","authenticated-orcid":false,"given":"Ji-Youn","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4499-5284","authenticated-orcid":false,"given":"James Chung-Man","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8074-0900","authenticated-orcid":false,"given":"Calvin S.H.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2817-9458","authenticated-orcid":false,"given":"Lynette L.S.","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Shum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2087-4963","authenticated-orcid":false,"given":"Sanjay","family":"Popat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lungcan.2026.109558_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"Suppl 2","key":"10.1016\/j.lungcan.2026.109558_b0010","first-page":"229","article-title":"British Thoracic Society guidelines for the investigation and management of pulmonary nodules: accredited by NICE","volume":"70","author":"Callister","year":"2015","journal-title":"CA Cancer J. Clin."},{"issue":"11","key":"10.1016\/j.lungcan.2026.109558_b0015","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1159\/000526818","article-title":"Incidental pulmonary nodules - what do we know in 2022","volume":"101","author":"Schmid-Bindert","year":"2022","journal-title":"Respiration"},{"issue":"2","key":"10.1016\/j.lungcan.2026.109558_b0020","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.232558","article-title":"Fleischner Society: glossary of terms for thoracic imaging","volume":"310","author":"Bankier","year":"2024","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.lungcan.2026.109558_b0025","first-page":"582","article-title":"Incidental pulmonary nodules \u2013 current guidelines and management","volume":"196","author":"Glandorf","year":"2023","journal-title":"Rofo"},{"issue":"Suppl 5","key":"10.1016\/j.lungcan.2026.109558_b0030","doi-asserted-by":"crossref","first-page":"e93S","DOI":"10.1378\/chest.12-2351","article-title":"Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"143","author":"Gould","year":"2013","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.lungcan.2026.109558_b0035","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1164\/rccm.201505-0990OC","article-title":"Recent trends in the identification of incidental pulmonary nodules","volume":"192","author":"Gould","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.lungcan.2026.109558_b0040","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.21037\/jtd-24-874","article-title":"Prevalence and management of pulmonary nodules: a systematic review and meta-analysis","volume":"16","author":"Chen","year":"2024","journal-title":"J. Thorac. Dis."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109558_b0045","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"The National Lung Screening Trial Research Team","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2026.109558_b0050","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ceh.2024.01.002","article-title":"Expert consensus on the evaluation and management of high-risk indeterminate pulmonary nodules","volume":"7","author":"Dawei","year":"2024","journal-title":"Clinical eHealth"},{"issue":"3","key":"10.1016\/j.lungcan.2026.109558_b0055","first-page":"282","article-title":"Pulmonary nodules: common questions and answers","volume":"107","author":"Langan","year":"2023","journal-title":"Am. Fam. Physician"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109558_b0060","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1148\/radiol.2017161659","article-title":"Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017","volume":"284","author":"MacMahon","year":"2017","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.lungcan.2026.109558_b0065","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.chest.2021.07.2168","article-title":"The probability of lung cancer in patients with incidentally detected pulmonary nodules: clinical characteristics and accuracy of prediction models","volume":"161","author":"Vachani","year":"2022","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109558_b0070","article-title":"Management of pulmonary nodules","volume":"1","author":"McNulty","year":"2019","journal-title":"BJR Open"},{"key":"10.1016\/j.lungcan.2026.109558_b0075","doi-asserted-by":"crossref","first-page":"38","DOI":"10.21037\/ccts-21-37","article-title":"Multiple pulmonary nodules: a management dilemma","volume":"4","author":"Kaaki","year":"2022","journal-title":"Curr. Chall. Thor. Surg."},{"issue":"11","key":"10.1016\/j.lungcan.2026.109558_b0080","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.annonc.2025.08.003","article-title":"Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"36","author":"Zer","year":"2025","journal-title":"Ann. Oncol."},{"issue":"10","key":"10.1016\/j.lungcan.2026.109558_b0085","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1200\/JCO.22.00051","article-title":"Adjuvant systemic therapy and adjuvant radiation therapy for stage I-IIIA completely resected non-small-cell lung cancer: ASCO Guideline Rapid Recommendation update","volume":"40","author":"Pisters","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109558_b0090","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1200\/OP-24-00784","article-title":"Management of stage III non\u2013small cell lung cancer: ASCO Guideline Rapid Recommendation update clinical insights","volume":"21","author":"Singh","year":"2025","journal-title":"JCO Oncol. Pract."},{"issue":"9","key":"10.1016\/j.lungcan.2026.109558_b0095","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/imj.16502","article-title":"Prevalence of pulmonary nodules detected incidentally on noncancer-related imaging: a review","volume":"54","author":"Das","year":"2024","journal-title":"Intern. Med. J."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109558_b0100","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1378\/chest.15-0630","article-title":"Management of pulmonary nodules by community pulmonologists: a multicenter observational study","volume":"148","author":"Tanner","year":"2015","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.lungcan.2026.109558_b0105","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cllc.2023.09.003","article-title":"Outcome of incidental pulmonary nodules in a real-world setting","volume":"24","author":"Vindum","year":"2023","journal-title":"Clin. Lung Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2026.109558_b0110","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/RTI.0000000000000768","article-title":"Risk and time to diagnosis of lung cancer in incidental pulmonary nodules","volume":"39","author":"Hammer","year":"2024","journal-title":"J. Thorac. Imaging"},{"key":"10.1016\/j.lungcan.2026.109558_b0115","article-title":"Pulmonary nodules and the psychological harm they can cause: a scoping review","volume":"86","author":"Hillyer","year":"2024","journal-title":"Respir. Med. Res."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109558_b0120","article-title":"Patients' experiences of, and psychological responses to, surveillance for pulmonary nodules detected through lung cancer screening","volume":"12","author":"Katsampouris","year":"2025","journal-title":"BMJ Open Respir. Res."},{"issue":"Suppl 11","key":"10.1016\/j.lungcan.2026.109558_b0125","doi-asserted-by":"crossref","first-page":"S455","DOI":"10.1016\/j.jacr.2023.08.024","article-title":"ACR Appropriateness Criteria\u00ae incidentally detected indeterminate pulmonary nodule","volume":"20","author":"Martin","year":"2023","journal-title":"J. Am. Coll. Radiol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109558_b0130","doi-asserted-by":"crossref","first-page":"19062","DOI":"10.1038\/s41598-023-46391-7","article-title":"Radiomics as a non-invasive adjunct to chest CT in distinguishing benign and malignant lung nodules","volume":"13","author":"Selvam","year":"2023","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109558_b0135","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/thorax-2023-220226","article-title":"Radiomics analysis to predict pulmonary nodule malignancy using machine learning approaches","volume":"79","author":"Warkentin","year":"2024","journal-title":"Thorax"},{"issue":"12","key":"10.1016\/j.lungcan.2026.109558_b0140","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1200\/JCO.22.01345","article-title":"Sybil: a validated deep learning model to predict future lung cancer risk from a single low-dose chest computed tomography","volume":"41","author":"Mikhael","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.lungcan.2026.109558_b0145","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.jtho.2024.09.106","article-title":"MA02.11 Validation of the sybil deep learning lung cancer risk prediction model in three independent screening studies","volume":"19","author":"Phellan Aro","year":"2024","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109558_b0150","doi-asserted-by":"crossref","first-page":"29172","DOI":"10.1038\/s41598-025-15053-1","article-title":"Patient and nodule characteristics associated with adherence to lung cancer screening in a large integrated healthcare system","volume":"15","author":"Yang","year":"2025","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.lungcan.2026.109558_b0155","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1513\/AnnalsATS.201803-173CME","article-title":"Models to estimate the probability of malignancy in patients with pulmonary nodules","volume":"15","author":"Choi","year":"2018","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109558_b0160","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","article-title":"International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma","volume":"6","author":"Travis","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"9","key":"10.1016\/j.lungcan.2026.109558_b0165","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification","volume":"10","author":"Travis","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109558_b0170","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of lung tumors: impact of advances since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.109558_b0175","article-title":"Multidimensional biological characteristics of ground glass nodules","volume":"14","author":"Chen","year":"2024","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109558_b0180","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/jama.2021.24287","article-title":"Evaluating the patient with a pulmonary nodule: a review","volume":"327","author":"Mazzone","year":"2022","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.lungcan.2026.109558_b0185","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5306\/wjco.v12.i4.217","article-title":"Oncogenic driver mutations in non-small cell lung cancer: past, present and future","volume":"12","author":"Chevallier","year":"2021","journal-title":"World J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.lungcan.2026.109558_b0190","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1164\/rccm.202101-0119OC","article-title":"Multiomics analysis reveals distinct immunogenomic features of lung cancer with ground-glass opacity","volume":"204","author":"Chen","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"23","key":"10.1016\/j.lungcan.2026.109558_b0195","doi-asserted-by":"crossref","first-page":"7472","DOI":"10.3390\/jcm13237472","article-title":"PIK3CA mutations and co-mutations in operated non-small cell lung carcinoma","volume":"13","author":"Cokpinar","year":"2024","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109558_b0200","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12967-020-02241-y","article-title":"The growth of non-solid neoplastic lung nodules is associated with low PD L1 expression, irrespective of sampling technique","volume":"18","author":"Bortolotto","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.lungcan.2026.109558_b0205","article-title":"Distinguishing EGFR mutant subtypes in stage IA non-small cell lung cancer using the presence status of ground glass opacity and final histologic classification: a systematic review and meta-analysis","volume":"10","author":"Qiu","year":"2023","journal-title":"Front. Med. (Lausanne)"},{"issue":"5","key":"10.1016\/j.lungcan.2026.109558_b0210","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/JTO.0000000000000487","article-title":"High discrepancy of driver mutations in patients with NSCLC and synchronous multiple lung ground-glass nodules","volume":"10","author":"Wu","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.109558_b0215","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.724692","article-title":"Molecular alterations in lung adenocarcinoma with ground-glass nodules: a systematic review and meta-analysis","volume":"11","author":"Wei","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109558_b0220","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1186\/s12885-025-13998-0","article-title":"Molecular characterization of early-stage lung adenocarcinoma presenting as subsolid nodules in a real-life European cohort","volume":"25","author":"Taj\u00e8","year":"2025","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.lungcan.2026.109558_b0225","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.athoracsur.2023.05.031","article-title":"The prognostic impact of epidermal growth factor receptor mutation in clinical stage I lung adenocarcinoma","volume":"117","author":"Yang","year":"2024","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.lungcan.2026.109558_b0230","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2024.1455502","article-title":"Driver gene alterations in NSCLC patients in southern China and their correlation with clinicopathologic characteristics","volume":"15","author":"Deng","year":"2024","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109558_b0235","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12957-025-03960-6","article-title":"The correlation between EGFR mutation status and clinicopathological characteristics, Ki67 expression and immune cell infiltration in lung adenocarcinoma with different radiological subtypes","volume":"23","author":"Qu","year":"2025","journal-title":"World J. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109558_b0240","article-title":"Multicellular ecotypes shape progression of lung adenocarcinoma from ground-glass opacity toward advanced stages","volume":"5","author":"Deng","year":"2024","journal-title":"Cell Rep. Med."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109558_b0245","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/annonc\/mdu505","article-title":"Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth","volume":"26","author":"Kobayashi","year":"2015","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.lungcan.2026.109558_b0250","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1007\/s00432-022-04289-3","article-title":"Distinct cellular immune profiles in lung adenocarcinoma manifesting as pure ground glass opacity versus solid nodules","volume":"149","author":"Qu","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.lungcan.2026.109558_b0255","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.3390\/cancers12123605","article-title":"Immune escape mechanisms in non small cell lung cancer","volume":"12","author":"Anichini","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"Suppl 2","key":"10.1016\/j.lungcan.2026.109558_b0260","first-page":"3161","article-title":"Predicting the EGFR mutation status of lung adenocarcinoma manifesting as ground-glass nodules based on 18F-FDG PET\/CT radiomics","volume":"63","author":"Shi","year":"2022","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.lungcan.2026.109558_b0265","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2025.1612081","article-title":"Relationship between qualitative and quantitative parameters of three-dimensional computed tomography, EGFR gene mutation, and ALK gene rearrangement in GGO-associated lung adenocarcinoma and their prognostic value","volume":"31","author":"Liu","year":"2025","journal-title":"Pathol. Oncol. Res."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109558_b0270","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00986-2018","article-title":"Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning","volume":"53","author":"Wang","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109558_b0275","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1016\/S2589-7500(22)00024-3","article-title":"Mining whole-lung information by artificial intelligence for predicting EGFR genotype and targeted therapy response in lung cancer: a multicohort study","volume":"4","author":"Wang","year":"2022","journal-title":"Lancet Digit. Health"},{"key":"10.1016\/j.lungcan.2026.109558_b0280","article-title":"AI-based pipeline for early screening of lung cancer: integrating radiology, clinical, and genomics data","volume":"24","author":"Batra","year":"2024","journal-title":"Lancet Reg. Health Southeast Asia"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109558_b0285","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s13019-022-02071-7","article-title":"Osimertinib showed efficacy on contralateral multiple ground-glass nodules after segmentectomy for lung adenocarcinoma harboring primary EGFR-T790M mutation: a case report and review of the literature","volume":"17","author":"Dong","year":"2022","journal-title":"J. Cardiothorac. Surg."},{"issue":"9","key":"10.1016\/j.lungcan.2026.109558_b0290","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1007\/s00432-020-03234-6","article-title":"Ground-glass opacity-featured lung adenocarcinoma has no response to chemotherapy","volume":"146","author":"Zhang","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.lungcan.2026.109558_b0295","article-title":"Immunotherapy for bilateral multiple ground glass opacities: an exploratory study for synchronous multiple primary lung cancer","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109558_b0300","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41392-024-01799-z","article-title":"The activity and immune dynamics of PD-1 inhibition on high-risk pulmonary ground glass opacity lesions: insights from a single-arm, phase II trial","volume":"9","author":"Cheng","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"18","key":"10.1016\/j.lungcan.2026.109558_b0305","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1158\/1078-0432.CCR-15-3101","article-title":"EGFR mutations and ALK rearrangements are associated with low response rates to PD-1 pathway blockade in non-small cell lung cancer: a retrospective analysis","volume":"22","author":"Gainor","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109558_b0310","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1002\/ctm2.149","article-title":"Synchronous ground-glass nodules showed limited response to anti-PD-1\/PD-L1 therapy in patients with advanced lung adenocarcinoma","volume":"10","author":"Wu","year":"2020","journal-title":"Clin. Trans. Med."},{"issue":"10","key":"10.1016\/j.lungcan.2026.109558_b0315","doi-asserted-by":"crossref","first-page":"S540","DOI":"10.1016\/j.jtho.2024.09.1002","article-title":"EP.07C.04 Adjuvant aumolertinib in resected stage I EGFR-mutated NSCLC: prospectively evaluating efficacy in residual GGN lesions","volume":"19","author":"Huang","year":"2024","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.109558_b0320","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2147\/CMAR.S290830","article-title":"Management for residual ground-glass opacity lesions after resection of main tumor in multifocal lung cancer: a case report and literature review","volume":"13","author":"Cheng","year":"2021","journal-title":"Cancer Manag. Res."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109558_b0325","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.athoracsur.2015.06.042","article-title":"Novel strategy for synchronous multiple primary lung cancer displaying unique molecular profiles","volume":"101","author":"Ye","year":"2016","journal-title":"Ann. Thorac. Surg."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109558_b0330","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1159\/000520473","article-title":"Bone metastasis of non-small-cell lung cancer showing pathological complete response to osimertinib monotherapy","volume":"14","author":"Shintani","year":"2021","journal-title":"Case Rep. Oncol."},{"issue":"7","key":"10.1016\/j.lungcan.2026.109558_b0335","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1634\/theoncologist.2011-0385","article-title":"EGFR mutation heterogeneity and the mixed response to EGFR tyrosine kinase inhibitors of lung adenocarcinomas","volume":"17","author":"Chen","year":"2012","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109558_b0340","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13045-022-01351-y","article-title":"Liquid biopsy: current technology and clinical applications","volume":"15","author":"Nikanjam","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109558_b0345","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jacr.2023.09.009","article-title":"ACR Lung-RADS v2022: assessment categories and management recommendations","volume":"21","author":"Christensen","year":"2024","journal-title":"J. Am. Coll. Radiol."},{"key":"10.1016\/j.lungcan.2026.109558_b0350","unstructured":"American College of Radiology Committee on Lung-RADS\u00ae, Lung-RADS Assessment Categories 2022. Available at https:\/\/edge.sitecorecloud.io\/americancoldf5f-acrorgf92a-productioncb02-3650\/media\/ACR\/Files\/RADS\/Lung-RADS\/Lung-RADS-2022.pdf. (Accessed on July 16, 2026)."},{"issue":"2","key":"10.1016\/j.lungcan.2026.109558_b0355","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s12055-023-01595-4","article-title":"Management of screening-detected ground glass nodules: a narrative review","volume":"40","author":"Omindo","year":"2024","journal-title":"Indian J. Thorac. Cardiovasc. Surg."},{"issue":"11","key":"10.1016\/j.lungcan.2026.109558_b0360","doi-asserted-by":"crossref","first-page":"7477","DOI":"10.21037\/jtd-24-1166","article-title":"A predictive nomogram for EGFR mutation status in lung adenocarcinoma manifesting as ground-glass nodules","volume":"16","author":"Ping","year":"2024","journal-title":"J. Thorac. Dis."},{"issue":"Suppl 6","key":"10.1016\/j.lungcan.2026.109558_b0365","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1158\/1538-7445.AM2024-4097","article-title":"Abstract 4097: LNP-mRNA neoantigen vaccines to intercept progression of pre-invasive to invasive lung adenocarcinoma","volume":"84","author":"He","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2026.109558_b0370","unstructured":"ClinicalTrials.gov, NCT06924398 | Postoperative EGFR-TKI therapy for high-risk synchronous resectable contralateral pulmonary nodules in patients with EGFR-mutant non-small cell lung cancer (ARMOR2501), 2025. https:\/\/clinicaltrials.gov\/study\/NCT06924398. (Accessed March 19, 2026)."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109558_b0375","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cllc.2023.09.005","article-title":"TARGET: a phase II, open-label, single-arm study of 5-year adjuvant osimertinib in completely resected EGFR-mutated stage II to IIIB NSCLC post complete surgical resection","volume":"25","author":"Soo","year":"2024","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.lungcan.2026.109558_b0380","unstructured":"ClinicalTrials.gov, NCT04591002 | A phase II, study of osimertinib to suppress the progression of remaining ground-glass opacity Nodule (GGN) in other lobes after curative resection for actionable EGFR mutation-positive stage IB-IIIA lung adenocarcinoma, 2026. https:\/\/clinicaltrials.gov\/study\/NCT04591002. (Accessed March 19, 2026)."},{"key":"10.1016\/j.lungcan.2026.109558_b0385","unstructured":"ClinicalTrials.gov, NCT05528458 | Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma, 2026. https:\/\/clinicaltrials.gov\/study\/NCT05528458. (Accessed March 19, 2026)."},{"key":"10.1016\/j.lungcan.2026.109558_b0390","unstructured":"ClinicalTrials.gov, NCT04789681 | Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial, 2026. https:\/\/clinicaltrials.gov\/study\/NCT04789681. (Accessed March 19, 2026)."},{"key":"10.1016\/j.lungcan.2026.109558_b0395","unstructured":"ClinicalTrials.gov, NCT03634241 | Pembrolizumab in preventing lung cancer in patients with stage I-II non-small cell lung cancer or high-risk pulmonary nodules, the IMPRINT-lung study, 2026. https:\/\/clinicaltrials.gov\/study\/NCT03634241. (Accessed March 19, 2026)."},{"key":"10.1016\/j.lungcan.2026.109558_b0400","unstructured":"ClinicalTrials.gov, NCT05526755 | A study of 5 years of adjuvant osimertinib in completely resected epidermal growth factor receptor mutation (EGFRm) non-small cell lung carcinoma (NSCLC) (TARGET), 2026. https:\/\/clinicaltrials.gov\/study\/NCT05526755. (Accessed March 19, 2026)."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109558_b0405","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4143\/crt.2021.822","article-title":"The impact of EGFR tyrosine kinase inhibitor on the natural course of concurrent subsolid nodules in patients with non-small cell lung cancer","volume":"54","author":"Kang","year":"2022","journal-title":"Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109558_b0410","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41392-020-00452-9","article-title":"The impact of postoperative EGFR-TKIs treatment on residual GGO lesions after resection for lung cancer","volume":"6","author":"Cheng","year":"2021","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:52:56Z","timestamp":1789145576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226006197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":82,"alternative-id":["S0169500226006197"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109558","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biology, detection, and management of incidental pulmonary nodules: the emerging role of targeted treatments. A review of the current literature and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109558"}}